<SEC-DOCUMENT>0001493152-24-045422.txt : 20241114
<SEC-HEADER>0001493152-24-045422.hdr.sgml : 20241114
<ACCEPTANCE-DATETIME>20241114092843
ACCESSION NUMBER:		0001493152-24-045422
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20241114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241114
DATE AS OF CHANGE:		20241114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			bioAffinity Technologies, Inc.
		CENTRAL INDEX KEY:			0001712762
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				465211056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41463
		FILM NUMBER:		241457774

	BUSINESS ADDRESS:	
		STREET 1:		22211 WEST INTERSTATE-10
		STREET 2:		SUITE 1206
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78257
		BUSINESS PHONE:		210-698-5334

	MAIL ADDRESS:	
		STREET 1:		22211 WEST INTERSTATE-10
		STREET 2:		SUITE 1206
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78257
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:BIAF="http://bioaffinitytech.com/20241114">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_BIAF_bioaffinitytech.com_20241114 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20241114_20241114 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001712762 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000004" name="dei:EntityCentralIndexKey">0001712762</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="biaf-20241114.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2024-11-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue.007PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2024-11-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:TradeableWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2024-11-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20241114__20241114_zepJNFGEltW3"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_903_edei--DocumentPeriodEndDate_c20241114__20241114_zFFhSVkfU2Ai"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November 14, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20241114__20241114_zRFRXjkPZew8"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000011" name="dei:EntityRegistrantName">BIOAFFINITY
TECHNOLOGIES, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20241114__20241114_zH3YEowQHp83"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20241114__20241114_zP2fIYa8nVo1"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000013" name="dei:EntityFileNumber">001-41463</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20241114__20241114_zehWYM8lG2Ne"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-5211056</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20241114__20241114_zGPY9ttY0Oka"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000015" name="dei:EntityAddressAddressLine1">3300
Nacogdoches Road</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20241114__20241114_z9N9CsAGO2Ua"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 216</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20241114__20241114_zcKYnBD6Puyd"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000017" name="dei:EntityAddressCityOrTown">San
Antonio</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20241114__20241114_zMAIZ8f6x6vl"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20241114__20241114_zalgNwMIZtmf"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000019" name="dei:EntityAddressPostalZipCode">78217</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--CityAreaCode_c20241114__20241114_zqfhIECnmWog"><span><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000020" name="dei:CityAreaCode">(210)</ix:nonNumeric></span>
<span><span id="xdx_90C_edei--LocalPhoneNumber_c20241114__20241114_zAFtmvdRdsid"><ix:nonNumeric contextRef="AsOf2024-11-14" id="Fact000021" name="dei:LocalPhoneNumber">698-5334</ix:nonNumeric></span></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices and Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 1.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20241114__20241114_zn7TB2SIOOza"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20241114__20241114_z9rJni96nh83"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20241114__20241114_zNmNUayfHdt8"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20241114__20241114_z2r9vqSyide2"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20241114__20241114_zu9QRBQVfq1g"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleantrue" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_zGhKecyAlKW2"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, par value $.007 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_zs7UwDYd7xKh"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember" id="Fact000028" name="dei:TradingSymbol">BIAF</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue.007PerShareMember_z5sETKCCky8i"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_z2wHbvT6Rp43"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember" id="Fact000030" name="dei:Security12bTitle">Tradeable
    Warrants to purchase Common Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_zK7V1rh1ZFNj"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember" id="Fact000031" name="dei:TradingSymbol">BIAFW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20241114__20241114__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseCommonStockMember_zcXNhq30w2J2"><ix:nonNumeric contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_901_edei--EntityExTransitionPeriod_c20241114__20241114_zEPGM7Yq6kOj"><ix:nonNumeric contextRef="AsOf2024-11-14" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.02. Results of Operation and Financial Condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>On
November 14, 2024, bioAffinity Technologies, Inc., a Delaware corporation (the &#8220;Registrant&#8221;), issued a press release that
included financial information for its quarter ended September 30, 2024. A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed
to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this
Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference
into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibit is furnished with this Current Report on Form 8-K:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release issued by bioAffinity Technologies, Inc. dated November 14, 2024</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 14, 2024</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BIOAFFINITY
    TECHNOLOGIES, INC.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></p></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Maria Zannes</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Maria Zannes</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">President and Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kUFuwjAQRU/AHUZRlwjilAopuzaiqCpUEURtt0MyFIvEE40dCkfqLesk0LJoLUu29ef9PyMHwTCY86MuSeD9YbWAjKq6REewoi0JmZx8RfL0HIM/V/ShrRM0rntewIQ9Q565G0WTjRe60oO2VMSg1FjdjqOJv8RqCukyGLR6wmarCzJOYwloCkiFa9HkUE69Q4ZHNlyduqhXEqvZeLtR2MtfEIUqghc+4CfL3sJikQSDYbcGwVy4qX3V7OjItCTMSqp8nO3p3911kzfWcRVnggXhpqQ3lHZKm3HaSL5DS37Gis3acb5fUrUh8ZQKo0iF9+eGfmC40OAY6jMPvQF0Dn9EX/mnKK9YNjQKw2lKst6h0D+Z16ZDqFHg0JJw07JQ+7+xLX3J+wbLqZW/ -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" style="width:220px"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%; vertical-align: middle"><IMG SRC="ex99-1_002.jpg" ALT="" style="width:280px"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies Reports $2.4 Million Revenue for Q3 2024</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expanded
CyPath<SUP>&reg;</SUP> Lung test sales to physicians in Illinois, Alabama, and Louisiana; now receiving orders from physicians in 11
states</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Number
of physician offices signed increased 75% over Q2 2024</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reaffirmed
$9.6 million 2024 revenue forecast for wholly owned Precision Pathology subsidiary</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAN
ANTONIO, Texas (November 14, 2024) &ndash; <U>bioAffinity Technologies, Inc.</U> (Nasdaq: BIAF; BIAFW),</B> a biotechnology company focused
on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today reported financial
results for the three months ended September 30, 2024.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Highlights</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generated
                                            quarterly revenue of $2.4 million in the third quarter of 2024.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
                                            than 1,300% growth rate for CyPath<SUP>&reg;</SUP> Lung orders in first nine months of 2024
                                            over full-year 2023.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
                                            of physician offices signed increased by 75% compared to the second quarter of 2024, setting
                                            the stage for acceleration of <U>CyPath<SUP>&reg;</SUP> Lung</U> sales in the quarters ahead.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            October 2024, CyPath<SUP>&reg;</SUP> Lung was added to the U.S. Federal Supply Schedule (FSS),
                                            a procurement system that provides the Veterans Health Administration and the Military Health
                                            System streamlined access to state-of-the-art healthcare products and services. Under the
                                            FSS contract, Veterans at high risk for lung cancer will have easy access to CyPath<SUP>&reg;
                                            </SUP>Lung through 1,380 government health care facilities. Approximately 8,000 Veterans
                                            are treated for lung cancer annually, according to the VA.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Referrals
                                            and word-of-mouth from physicians, including key opinion leaders (KOLs), continues to be
                                            a key driver for expanding CyPath<SUP>&reg;</SUP> Lung in states beyond Texas; now receiving
                                            CyPath<SUP>&reg;</SUP> Lung orders from physicians in 11 states, up from eight in the second
                                            quarter of 2024. In addition to previously reported orders from Pennsylvania, New Jersey,
                                            North Carolina, Arizona, Michigan, California, and Ohio, physicians in Alabama, Louisiana
                                            and Illinois have also begun ordering CyPath<SUP>&reg;</SUP> Lung tests.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Added
                                            new sales representative to target increasing opportunities in Texas.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
                                            to advance new product development initiatives in collaboration with Brooke Army Medical
                                            Center, the U.S Department of Defense&rsquo;s largest military health organization, focusing
                                            on tests that use the Company&rsquo;s artificial intelligence and flow cytometry platform
                                            for diagnosing COPD and a companion test with bronchoscopy.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Economic
                                            study</U> published in Journal of Health Economics and Outcomes Research, a peer-reviewed
                                            journal, concludes that adding CyPath<SUP>&reg;</SUP> Lung to the standard of care for Medicare
                                            patients with a positive lung cancer screening could have saved an average of $2,773 per
                                            patient for total cost savings of $379 million in 2022.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awarded
                                            a Certificate of Grant of Patent from the Japan Patent Office for the Company&rsquo;s unique
                                            method using flow cytometry to predict the likelihood of lung disease, including the CyPath<SUP>&reg;
                                            </SUP>Lung diagnostic test for early-stage lung cancer.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointed
                                            William Bauta, Ph.D., as Chief Science Officer following the retirement of Vivienne I. Rebel,
                                            M.D., Ph.D. Dr. Bauta joined bioAffinity in 2016 as Senior Vice President. Previously, he
                                            was Associate Director of science at Genzyme.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successfully
                                            closed a $2.7 million registered direct offering and concurrent private placement to fund
                                            continued growth.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Commentary</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are pleased with the continued progress we achieved in the third quarter, highlighted by a 75% growth in the number of physician offices
signing on to offer CyPath<SUP>&reg;</SUP> Lung. This significant expansion not only reflects the increasing recognition of our test&rsquo;s
value in early lung cancer detection but also lays a strong foundation for accelerating sales growth in the coming quarters,&rdquo; bioAffinity
President and Chief Executive Officer Maria Zannes said. &ldquo;With CyPath<SUP>&reg;</SUP> Lung now being used in 11 states and its
recent addition to the U.S. Federal Supply Schedule, we are making meaningful strides in broadening access to this innovative diagnostic
tool.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
focus remains on expanding our operations and strengthening our foothold in this rapidly growing market,&rdquo; Zannes continued. &ldquo;Our
strategic approach in Texas has resulted in a robust sales and support infrastructure that has us well-equipped to meet rising demand
and accelerate our nationwide growth. As we look toward the future, we are confident that these efforts will not only fuel our success
but also advance our mission to enhance patient outcomes through groundbreaking, noninvasive cancer diagnostics.&rdquo;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Third
Quarter Financial Results</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
for the third quarter of 2024 was $2.4 million, compared with $298,000 revenue for the prior-year period. The majority of the year-over-year
increase is through the acquisition of Precision Pathology Laboratory Services, LLC (PPLS). Revenue is primarily generated from patient
service fees, including billing for CyPath<SUP>&reg;</SUP> Lung tests, with additional revenues generated from histology service fees
and medical director fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses were $274,000 for the third quarter of 2024, compared with $330,000 for the comparable period in 2023. The decrease
was primarily due to higher R&amp;D laboratory supply and equipment costs following the acquisition of PPLS in the prior year period.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
development expenses were $94,000 for the third quarter of 2024, compared with $106,000 for the third quarter of 2023. The decrease was
primarily attributable to higher professional fees in the prior year period related to evaluating the clinical strategy for the Company&rsquo;s
Food and Drug Administration (FDA) pivotal CyPath<SUP>&reg;</SUP> Lung clinical trial.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
general and administrative expenses were $2.4 million for the third quarter of 2024, compared with $2.0 million for the comparable period
in 2023. The increase was primarily attributed to an increase in sales personnel and services to support the launch of CyPath<SUP>&reg;
</SUP>Lung, together with acquired general and administrative costs from PPLS.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the third quarter of 2024 was $2.0 million, or $0.16 per share, a $0.3 million improvement from a net loss of $2.3 million,
or $0.26 per share, for the comparable period in 2023.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents as of September 30, 2024, were $0.8 million, compared with $2.8 million as of December 31, 2023. Subsequent to the
end of the third quarter of 2024, bioAffinity Technologies raised aggregate gross proceeds of $2.7 million in a registered direct offering
and concurrent private placement closed on October 21, 2024.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
bioAffinity Technologies, Inc.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer
treatments. The Company&rsquo;s first product, <U>CyPath<SUP>&reg;</SUP> Lung</U>, is a noninvasive test that has shown high sensitivity,
specificity and accuracy for the detection of early-stage lung cancer. CyPath<SUP>&reg;</SUP> Lung is marketed as a Laboratory Developed
Test (LDT) by <U>Precision Pathology Laboratory Services</U>, a wholly owned subsidiary of bioAffinity Technologies. For more information,
visit <U>www.bioaffinitytech.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this press release constitute &ldquo;forward-looking statements&rdquo; within the meaning of the federal securities laws.
Words such as &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;predict,&rdquo; &ldquo;forecast,&rdquo; &ldquo;project,&rdquo;
&ldquo;plan,&rdquo; &ldquo;intend&rdquo; or similar expressions, or statements regarding intent, belief, or current expectations, are
forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements
regarding accelerating sales growth in the coming quarters; broadening access to CyPath<SUP>&reg;</SUP> Lung; expanding the Company&rsquo;s
operations and strengthening its foothold in the rapidly growing market; the Company&rsquo;s ability to meet rising demand and accelerate
its nationwide growth; the Company&rsquo;s ability to advance its mission to enhance patient outcomes through groundbreaking, noninvasive
cancer diagnostics; and the ability of the Company to address the need for noninvasive diagnosis of early-stage cancer and diseases of
the lung and broad-spectrum cancer treatments. These forward-looking statements are subject to various risks and uncertainties, many
of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from
those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially
from current expectations include, among others, the Company&rsquo;s ability to accelerate sales growth and expand its operations; the
Company&rsquo;s ability to meet rising demand and accelerate its nationwide growth; the Company&rsquo;s ability to advance its mission
to enhance patient outcomes through groundbreaking, noninvasive cancer diagnostics; the ability of the Company to address the need for
noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments, and the other factors discussed
in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2023, and its subsequent filings with the SEC, including
subsequent periodic reports on Forms 10-Q and 8-K. Such forward-looking statements are based on facts and conditions as they exist at
the time such statements are made and predictions as to future facts and conditions. While the Company believes these forward-looking
statements are reasonable, readers of this press release are cautioned not to place undue reliance on any forward-looking statements.
The information in this release is provided only as of the date of this release, and the Company does not undertake any obligation to
update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities
laws.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contacts</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julie
Anne Overton</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
of Communications</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jao@bioaffinitytech.com</U></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>Dave
Gentry<BR>
RedChip Companies Inc.<BR>
1-800-RED-CHIP (733-2447)<BR>
Or 407-491-4498<BR>
<U>BIAF@redchip.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Consolidated Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">September 30,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2024</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">December 31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2023</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">756,580</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">2,821,570</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts and other receivables, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,327,168</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">811,674</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,363</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,484</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">440,027</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">321,017</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,549,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,972,745</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">418,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">458,633</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Operating lease right-of-use asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">493,687</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">370,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Finance lease right-of-use asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">877,115</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,165,844</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,404,486</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,404,486</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">789,722</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">833,472</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,676</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">16,060</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,552,014</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,221,552</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">782,937</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">604,789</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">904,252</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,149,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Unearned revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,404</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,058</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Operating lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,710</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,708</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Finance lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">387,780</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">365,463</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Notes payable, current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">267,081</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,491,164</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,247,829</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Finance lease liability, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">835,467</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Operating lease liability, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,139</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">283,001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Notes payable, net of current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">21,679</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,430,989</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,366,297</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Preferred stock, par value $0.001 per share; 20,000,000 shares authorized; no shares issued or outstanding at September 30, 2024, and December 31, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Common stock, par value $0.007 per share; 100,000,000 shares authorized; 13,424,648 and 9,394,610 issued and outstanding at September 30, 2024, and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,064</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,762</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,708,374</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,393,972</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(50,677,413</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(44,604,479</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,121,025</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,855,255</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,552,014</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,221,552</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unaudited
Condensed Consolidated Statements of Operations</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">Three Months Ended <BR> September 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">Nine Months Ended <BR> September 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; font-weight: bold; text-align: left">Net Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2,350,386</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">298,484</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">7,154,429</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">319,143</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Direct costs and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,440,158</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,704</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,421,309</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,025</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">274,497</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">330,376</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,070,569</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,035,118</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Clinical development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,705</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">194,127</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,310</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,364,592</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,023,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,023,311</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,576,708</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">151,298</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">57,569</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">452,005</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">100,805</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,324,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,592,988</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,161,321</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,949,966</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,973,864</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,294,504</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,006,892</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,630,823</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,228</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,541</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,971</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,631</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,785</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(67,430</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,801</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Other income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,683</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,683</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,606</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(14,697</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(17,100</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(10,186</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(17,100</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total other income (expense)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(24,417</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,914</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(54,392</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">85,676</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net loss before provision for income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,998,281</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,288,590</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,061,284</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,545,147</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,559</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,294</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,650</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18,700</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,000,840</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,290,884</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(6,072,934</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,563,847</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net loss per common share, basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.16</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.26</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.54</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.65</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average common shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,391,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,696,554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,237,324</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,551,154</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !M 08# 2(  A$! Q$!_\0
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M:K/=F." ZG:WEK!IMG%9>2WDV_VBYO&NUEG2&W6*4O9:[_U_P165]-OZ_P"
M?J]17S]^S!\5M;^,_P &_#7CKQ'8V]EK=U+J.G:B;.-HK.^GTJ\DM#J%M"Q;
MR!<A%-Q C-'!>I=0Q$1(BCZ!IBVT"BBB@ HHHH **** "BBB@ HHHH ****
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MT35M8TG0-.N]8UW5-.T72;"(SWVJ:M>VVG:=90@A3-=WUY+#;6\09@#)-*B
MD#.2*0B#7/#^A>)M/ETGQ%I&G:WIDQ!EL=4LX+VU=ESM8PW".@=02 X 8 D
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M:W"Z-XB\/M:C3#X?GE+7$ET)3>HL4<>R1V:2Y7KVOH]/\QI+E>O:^CT_S/\
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M!_QHCT"QNBL0N#IGB_PGKMSJ-J'8>:8&NO#&F7#(I*K) C,!NS7]&M?R%_\
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M4O@GXIF+QK\$]8=OEMF71O$*:/X.NIV=8K">374E<-!*:U?V9])F_P""N?\
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MX\Q%"@O_ %]_^87_ *^__,_E0_9O_9?\>_&/]DSX[_M!?LXR6^E?MC_L?_\
M!3C]L[XJ_ '5?*C/_"8VL/C:P?Q]\#_$#EHFNO"OQ6\-1W6BR6,LJ0C5Y-.D
M,MM;3WLK?)/AKQCX@_:Q_96_X*#_ +5WPU^&_BW4M*\$?\%5_P!GS]KOQY\(
M;BQ:3QJ? GP\T'PU>?$GPK<:.BDWU[X9:YOKV^MC$Q?3-!NKWR!)%Y*_VR^'
MO"GA?PC;7MGX4\-Z#X9L]2U6_P!=U&U\/Z1I^C6U_K>J2";4]8O8-.M[:*ZU
M349@);[4)U>[NY0)+B61QFJGASP+X)\'MKC>$O!_A?PNWB;4Y];\2'P[H&E:
M*?$&LW0VW.K:T=-M+;^U-3N%R)[Z^\^ZF!(DE;)HO^EO3L%_TMZ=C\P?VD?^
M"IO["A_8Y\>?$CPM\>?AK\4G^)7PS\2^'/AM\+/"7B/2M?\ B7\1?&?B_P /
MWFBZ!\/;'X=V5S-XIB\0:EJ^H0:3J6GW^EV[:6WVQM0,,=K,R_F;\&;#2_V)
M_P!I'_@BOX2_::\9^%OA1?> /^"?7[0'A_QAJ/Q \2Z3X=TO0?$^M#P;J">%
M+K6-7NK2P2]TR:[DT6"W,X9WT]XH5;9BOZ$O#?[(G[*?@WXA7'Q;\)?LU_ ?
MPQ\4KJ=KJX^(F@?";P)I'C66Z=BSW+>)K#0H-8%PS$LTZW8E+$DODDGT#QY\
M&_A#\4IM/N?B;\+/AS\1;C289[?2I_'7@GPUXMETV"ZDBEN8;"37],OWLXKB
M2&&2>.W,:RO%&SAF12"_]?*P7_KY6/Q(_:&_:(^#/PO_ ."EO[(G[=>L?$7P
MMXI_9$\:_ 'XO?LF7GQV\,Z[I7BGX7?";XOZAXRT#QKHS^+/$NC75]8>'8/%
M%E92^'?[5N)([:VE:Y&HSVMG!-()O^"G'QZ^#?[7U]^R7^Q=^S1X_P#!WQQ^
M-OCG]K#X%?%J_C^%^O:9XWL?A+\)_A/XA?Q?XT^*OC'7/#=QJ6G^&K"RTZ%=
M+TY+RY@O=3FU*XM[.-Y(S')^UMK\%O@]9>!=0^%]E\*?AO9_#75C='5/A[:^
M"/#-OX(U%KUD>\:]\*PZ8FAW373QQO<--8NTKQHSEF12,/X1?LX?L^? "+4X
M/@7\#OA)\'(M:?S-83X8_#SPGX&_M5]XD!U$^&M)TUKT"15<+<&10X#@!N:+
M_@%_P/PV_8X^*G@W]G37?^"D'[#?QG^/.E_LA?M*>-?VLOV@/CO\*_BYXX3P
MOIJ>,OAW\=9K36/ ?Q9\!7?Q%5/!/C:_\/1:?):ZMH5_=7JV%S!#87EL7CO(
M[?\ .WXY_M4>-_B/^PO^WOX*^,W[8&B_M.^'OA)_P4$_98^&OP5^+VJ6/PN\
M(1>-/#6C>/?AMXR\3'1(OA[INBZ!K7]E10ZKJFJSV1U1K#3=-NKV2XBL48K_
M %P_%W]GCX"?'^PL=+^.GP5^%/QCT[3)/.TVR^)WP_\ "OCFWT^4DDO8Q^)=
M+U);0L22WV?R]QY;) JK'^S3^SI%X2T?P#'\!?@RO@;P]<R7N@^#1\,?!?\
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3Q:T_3FBBDW?5B;OJPHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  T 4 # 2(  A$! Q$!_\0
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MVEGS':7UU:7C?) X;^HW]NO_ ),^_:(_[)EK_P#Z+CK\1_\ @BI_R<5\2/\
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M>98.-;#R=DXUUBL+-MJ/NIUJ5&I#$J.D,=@IRLHXJ+?]/G@GXQP? +_@FSX
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MIDU[6]"\7%XA>W-C!8Z?-HUMI>I6#R0ZRJZUO;4M/T^>SM)XYKN[;\4?'W[
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MD:!+K5Q/<V?AS1XEBT_3+2);6&00RZB]I;W-_<(/Y6?@5_R?M\.O^SFM._\
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' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>biaf-20241114.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayMGbP9z5Z8WekhvWB+bTlKjyIlNkq28i4ijCaGEXQJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BIAF="http://bioaffinitytech.com/20241114" elementFormDefault="qualified" targetNamespace="http://bioaffinitytech.com/20241114">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bioaffinitytech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20241114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20241114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20241114_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="BIAF_CommonStockParValue.007PerShareMember" name="CommonStockParValue.007PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BIAF_TradeableWarrantsToPurchaseCommonStockMember" name="TradeableWarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>biaf-20241114_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bioaffinitytech.com/role/Cover" xlink:href="biaf-20241114.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue.007PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue.007PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>biaf-20241114_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="BIAF_CommonStockParValue.007PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_CommonStockParValue.007PerShareMember" xlink:to="BIAF_CommonStockParValue.007PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_CommonStockParValue.007PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $.007 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="BIAF_TradeableWarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:to="BIAF_TradeableWarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_TradeableWarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Tradeable Warrants to purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>biaf-20241114_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bioaffinitytech.com/role/Cover" xlink:href="biaf-20241114.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_CommonStockParValue.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue.007PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue.007PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="biaf-20241114.xsd#BIAF_TradeableWarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFTradeableWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45660604422624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOAFFINITY
TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001712762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5211056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300
Nacogdoches Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Antonio<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-5334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember', window );">Common Stock, par value $.007 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $.007 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember', window );">Tradeable Warrants to purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Tradeable
    Warrants to purchase Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue.007PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_TradeableWarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M'RQ/W"?W5[S2/$_3+,-V=+N-,MAB^Y9E\(U'P[B!!Y8',OW97N/=QB?D]3G
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M;%!+ 0(4 Q0    ( )5+;EE'WS=![@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )5+;EF97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ E4MN61UBHZ#Q!   D!0  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )5+;EG@]#J)J@(  # ,
M   -              "  30-  !X;"]S='EL97,N>&UL4$L! A0#%     @
ME4MN69>*NQS     $P(   L              ( !"1   %]R96QS+RYR96QS
M4$L! A0#%     @ E4MN6:K$(A8S 0  (@(   \              ( !\A
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( )5+;EDD'INBK0   /@!   :
M              "  5(2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( )5+;EEED'F2&0$  ,\#   3              "  3<3  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ($4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bioaffinitytech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>biaf-20241114.xsd</File>
    <File>biaf-20241114_def.xml</File>
    <File>biaf-20241114_lab.xml</File>
    <File>biaf-20241114_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "BIAF",
   "nsuri": "http://bioaffinitytech.com/20241114",
   "dts": {
    "schema": {
     "local": [
      "biaf-20241114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "biaf-20241114_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "biaf-20241114_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "biaf-20241114_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://bioaffinitytech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "auth_ref": []
    },
    "BIAF_CommonStockParValue.007PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20241114",
     "localname": "CommonStockParValue.007PerShareMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $.007 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "BIAF_TradeableWarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20241114",
     "localname": "TradeableWarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tradeable Warrants to purchase Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-24-045422-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-045422-xbrl.zip
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M2Z2':(3O5F^S72E(!5(P;P7]=M0'/ZVVEP3_P4C4%F!KW"+ZLYA!\AU5P*-
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M<'KE]$]. Z:0"&^Y%<"^835M ?TVQ"#M3B^2QK>5;X]<T5/PR]BWMVB!""7
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MWF=KS,D'LED0KM7KF$ ;V!Q?$<E/_RCG(!UMM4&4BLUX>H6VF*-'&8_^(DM
M6S&I3V09OQ-C<XY#@A<Q^8(YQS1-YNQ>G):UF')6*@6C=ER\->)>4JT2O&."
M_>#O!8YU#,LB4%$&2AG:YJ6@*J7?BN+W&SKGTG!7SYZ+G R2-8/&D5$IG%/4
M:DM'I12AWY3LF\>_[P>$F!.2J?C8.8FJ")V T3!JA*-4^0>(;JT%$BE%2OM]
M24E(<+)BCZ.01!DDXL.!#?'+U_<LV"F:18E:A9J[;7  F9*MK^]SWN: (;VE
M"PF2&LL-?"$.',J#7\=X9;"O[;?5Q$9;11O7=GK1R"9'>BN7&B1%KIKY/4D"
M'FWEO=6V>M1DUAO=8++1]A6-7P@TC<$D5+2..O:/9!4E*5<WV\L1IZ4; _2V
MN_Y6V_I88!1[ 4T?A^!H40U"990CCBXHW>'X(]DRWH9/76:;&I-)'9:JQBM&
M#,9 -#(MRL2.B/C7#O.4\/BY$XJ&TC87@%4=#4WF%1UF;R @I=PM(W..:1+)
M#JP3DJ;4^N4&8+9QZ:'IO.($, =?DI1ZMZ3,UB2.Y<,9F'9W*":Q;5I@PSHO
M3:57Q(#V0&94!,I#_,'FZE'.SL4TJ6=E*WJ7\#1LM_%3BKU%2'?8DR(5AF2<
M(Y(JSX1T,-10VJ8'L*ISH\F\(L;L#60EDR.E=P_)%0U[(5+JW "BV33CD8L\
MA*/NK L-H78)QG64!#C.O%R+;?K7*QU:VX" =G5(&D*O0('<@;!D 04S*L0I
M,/\AF/?#I:)T TO#JAF54N8A*+JW+DRDW@DDESO.:Z[A$0>6VL*DRVS!":3S
M I0.<XU'DC)Y#11'(] 53:/T62YNN-T9GD$R2VRQ 9DKF-#W>\$"8$IG(),A
MJ4.9T$G+%]\2T%2N* &KH\OL$F V6:>@KO&(!*,Q@(:#5BWP<4+$I>B9.(ZG
M-"3[7\DS6*^&SBX3@,TZ%)K((RK,S@ L<C%2:B3D3L"XY]$&\^=9%'0,%4VA
M730@HW4V=)5'< #6 #IR-9I-+UV.)'.\GX8"U&@998OS.B@!]79AZ;!=9P80
M>X1.NT. (!&$ZE$N09K2@/$MJSSN<,EVH@-\OF0A/$/IB+(+5:\JU-%J#?$(
ML#X^ <QJH:^R9U(0DXNJ50%(EN"$N(LP%"<JR?^[B2@9@_4W:NW2U6*WSI1!
MZ!%)L#N GUSYJOB 9 RZH[Y ,SFBJA/WT$SZ0C/Q&IK)2Z"9/S%/H#D[HJIG
M[J$YZPO-F=?0G+T(&M'P3ON:2_'QCL_9D^GA;%#I!)FF52,P!YE_N#2\=<$B
M ^1\1H:XQ$1-K.[X/6>/$0W@*3,D=P(,8-I(C:;U#QVSP2Y^R@EQ$>>TK\DF
MY9U_)(7,32]3-VGN8C*-?Y#4C75V+IG:)1+W+$EQ_-]HVWHA;A8[P<-HV A)
M3>D?*B9[7<!D,4@$N;BPSG&57V@8EY)I^ZU]VVRR57[%7-WI!00F1\W\%MG=
MDTQDNYDEHYQ@H$>H[[;6R 9391M7]OG1Q$U#C196?]="X^(/6:;:B^_7C,(/
M"#0EMEH:,E>TMK[?BQ8'3.FMKF1(Z1S=C9?IOA)S]UW99VUDU^V4 WFQPXO6
MU=TTANEBO^76_,*C5!Q9YIG9T?Q;'M-S@X#.5BNWVBQ:W"CRHO7;G.DDY%I4
M%UO&8L;B*(C2B*X^B(M/'F%3K4PB6T# !@L:F@HO4 !M-3*YE$)4*"U#<,]5
M&BLB&D(M I19'OG=<FD<[=O$MJ#H-ES  2N]@*33G@Z+"!@&E0B4A2 5XQ:;
M:9+L"#\*'D.((X1 \P!(#;V/.$$F.Z'* EVR-2/!3HR/S^/)8AZEC21T9HFU
M,0DP5XY(VGXOV !,-?(4RGTR >MX\M?%WU 19;GY;YG,ERB&Q-GS9L%B(/N4
M464+@A:+!0<&B1<HP+YT&FX9RJ4HT[K(3E4S:ZB.MM\6 $9;1=/7=GK1Z"9'
MIB2EA[9VU.5?[8.U,$6 !0EFF>VNWV12[_ZK&B\0:#'6N"C)I:C0NEB0<!BR
M5MV3@)6S2<"J8Q*P\G$2L.H["5@YFP04A\U2A(A^Z6X11RL,)"=L5=N&HL6R
MSH=!ZA4JL#^PSRA#T"'&=D9+E>),OBN);]3QK\4'0RT!G;6<EFTVRZ26)I$7
MC+0Y:Z2US)+.5<1(JFUSL0NCE(29F>N(8AI$."[3(YKNB'>'6*.EI_D2G Z]
M'PSU,]G *0LK<AF6@8=4E[9OI6</8'PA<?PK94]T1G#"* FS>RFF;XK:]7:?
MF.FP77]H!A![@5,?A\"C,S)H^""C4!&6WPES0M)G%N]HBKE:2\Y-/1.@LTL.
M8+-.C";RB!2S,X"04HPRM9L%VEGVB'*2E;T$$JP@)+>\7+O5M+9JVZCUB)E6
M@] :[CSGQV%NG$4Y6F*9$HZ#-'HD[W&*<V]@?2&Y[465;:;UU90FK4<(M1H$
MUT^6,3)5#"Z8<I8RAE^*J=:*M3PEKJGL)XYI6&SFCBDE'N%A\M6208:C0NN$
MA=D&Q_&[71)1DL #D::RRX+18IV%FL0C%DR^ !:4%!5:)RQ<;0A?B>'M%\Z>
MTG6>GQ6L&Z"VRT:KY3HC1JE'K+3Y Y@I0E 64Z34=0//_I!0/,NR"-?4(+6,
M#6A68Z:A\PD8R%R#EI@$\G[++4O1G*%/"4'IFJ"K_)W U4SP63FNWC02!')!
M1#8KIR'F)H3:Q-;?.@(:;KQ[I*'T J1.>_![2,H(5(18IN9.,,RKUW'*A'R7
M'KC:H3O$%D%]S1<<=>F]H*FG29TI%5:_N%:!ZKV(+K,959/;PU.\FLCRS-A@
M4)L85Q1>, +:@J;%U7<%N,F=MUO$47 =,PS?9:EI+&?,:]K3DN4=!!X1T'0%
MI<A30J243MK_':8/?+=-@^=[S@)"Y%-62=E;==U_ZQEMEYFCJE2GJ5>H1YP=
MXQ<@\% $JI3QJC)BN;R95WF)^6R-Q0F\VZ6)'$&%,?@N>&N0Y:\7>E1 ^Y*A
M)<(C]'K8A+YPJ+Q1_A7*@E$EVM'U67+( DC"=\\?R9)PN>Y@3O;I.W&@AY8K
MC!ZQMJ_>>E='OYCK#/0"PF/=0I=Z":H6@!;R&;&\"/2;+ 2I4DSO+Z]NNA&?
MQ.9BD_BQP D16_X/4$L#!!0    ( )5+;EFE&&N;V @  $=J   5    8FEA
M9BTR,#(T,3$Q-%]P<F4N>&UL[9U=<^(X%H;OMVK_@Y>])D#2\]&9SDX1$J:H
MZ>ZP@>G>F9LN80M014B49 ?X]R.9CP"6Y$-/FN/=VEPD!(ZD\SY'EG5LR;S[
M>3GCT3-5FDEQ4VM=-&L1%;%,F)C<U'X;U-N#3J]7BW1*1$*X%/2F)F3MYW_]
M_6^1^7GWCWH]ZC+*D^OH3L;UGAC+GZ*/9$:OHU^HH(JD4OT4?2(\L^_(+N-4
M11TYFW.:4O/!NN'KZ+N+RS>CJ%X'U/N)BD2JWQY[NWJG:3K7UXW&8K&X$/*9
M+*1ZTA>QG,$J'*0DS?2NMN:RN?E9%W_'F7BZMK]&1-/(\!+Z>JG93<VVNVEV
M<74AU:1QV6RV&O_Y\'X03^F,U)FPW&):VY:RM;C*M=Z^?=O(/]V:%BR7(\6W
M;5PUMN[L:C:?LH#]GB>:7>O<O?<R)FD>]M)F(J^%_:^^-:O;M^JMR_I5ZV*I
MD]H6?DY024X?Z3BR?TWT=JV.F"3C,1,L7:4TGMJX-:Q-HR--OS0.YZ6GBHYO
M:B-&QJ:1RS>M5NN-;>*?!T;I:F[ZIV:V>]6B!JCY7(ZF\<5$/C=HG*S;[C_/
M[YB.N=29HH<^;'M;H:#UR[[('<R=<];R>D[>*V4/I5=PU%O3ZSG;7A"5#-G,
M#"ROX'"PMM=SNB<T2Z@:*F('Q+921$SHC(I4?[7GY55^*_?[DK.84=U7,GXE
M]UU5AMR?*ZJ-U'S8>6_>."A"EZD9VFFRK<A*.'&42%EJRVS&[U94MX-]9NF:
MEVO+C3];C[B,#YS@=E"4"L GH6S-Q[QXX6/^^9(WU![I5)$XW=;$R8CRO/XO
MQN;(I/&7O1H3/<I'Y4S7)X3,-Z'CJ=Z^\^+CYHTO]L27=[TA&7'J<'1C>&QW
M[.U^5-OJT'.B=AW#O#P(:?%DLK%HS(DR]=7C*>.[WC!6<N;#MVE0!KV6RO1;
M,\5I-M%YFZY/>^:E!C#?LT7F[N$:AK_G_B8 EQ4(0(<3K1_&@U3&3^TE@\2A
M6.2_,1Q%%;O# BLH^R[=R1EAPA\-EVW%PN#K6D<1<2G9A.)K(U&<'-_VVEUS
M-IK-I,@;ZA.5)SD7S>8/?:H&4Z/L YV-7DZ@>\AM86#9LA#LCOQO!-_?A;;4
M3Q!3Z"^O&0P[;Z+V0/U,[,POU4/9SU0\-<G3GGO!F)Q6!3 T5[BA^1HL?S5"
M)T[JMA/)H:G1/:<[M ""_U;<_7.-+?>"QRA8VZ;]Q/K0Y63BYGID @3;0B7K
ME(6%]H[J6+&Y!51"^, 2>U0_#;1#)-((\4@GS&8FUI6=AO"0X2F"/7B?-(@$
M92.%HBU$1O@CG4M5$H%#2R#X-Y4 [Q*)Q/O?&5$I57P%05XP!E+_KA+4/5*Q
M9B5FUJ29!04A7[0&HO^^$NA]8I'8#Z:4<WOYG A0OW?9 _G_4 G^?L$5B,#]
MLYT,&#7P(.P5 <;AQ\K%H2 ;*10FFV8R,3(4( @%8R#^MY7 [Y&*"OY>)%#L
M.U-P0E4AZD<ZD9AWF8X)7WO4->^YKB/ON>XPA[+'S69+]:+R_YT2!::_9PQE
MCYO@EF@],_E.IM2!,\$!QV\-98^;VI:I/3/\>Y&R=&774'W,/!>(C5G1"@H;
M-YWUJ4.!O+V8(5*[1BP$^M@2"ALWBPVI1 '>,0XKPGLBH<M?Z2I$O& *18Z;
MO09UHC#O*S8C:C5@<?EX4K2%4L?-6<-*4; /R;*7&+?9F*T78);3]Q:!!@$W
M807I1HE%3\12S>7>5>N.S,P1NNK()#CLEQ2$Q@4WDSV! 4ITVDEBN.G-'ZND
M%8J)TQQ\%ZL"D0CHK0C_R]/X7\+YXV:XI7HKPO_J-/Y7</ZX66ZI7DS^'?/R
M00WEPG/[W&L,98^;Y99HQ22?^_^@^DH^L_7NE3+\A1+0&%0A^0VK1CT$UC,"
M2/_?6D+!5R$1=JO$!-Z7.B7\#S8OFXBZ[:'PJY 2AQ2?^_+FN@/8ZR*^M5)'
M)E#0N%FP4]>YV=I0*TK\'?K0 DH6-[5UJ3HSV/?2WI292A&\+%RT@@+&S5%]
MZLX].-O-:=H[*NQ]#%ZTASOT'NLY,\_/BJ7& [NZ.Q.;ZT&>&W@>4RAGW,0R
MJ//,S ?Y;LV4B<D'X[EBA+N!N^R@M''32+_",Z/NJWSC C73]WS%FMW8JA[&
M8]_H'+*'HL?-(LL5XX:@IW5&U:F!<)2"A@,WH82J/_<01./,C(BKUN5H:/=J
M>P:@@A44.FXRZ5-W9L@?Y69[_F U&TGNWUGC-(2BQDT= QK/3/O #S?G(Q,H
M8=R<T:D+:;BX7\93^YP,_V(,MR64-&X.&5*)-CY/0./SY,3Q&3>7]*E#@KQ>
M.V^.L8<19Q/BWY\7+ #>JU0)] '-Y]X>F6^;L@\"4[/<CZYYX>;O,8621]Z*
M&M)Y;N99PE*:K%WJ,D%$;'*TG0S/!8#R4M!((.]5!:I'N>_PF7+^JY +,:!$
M2T&3=<H0NO7@+0(-1Q7N>Y;H1HG%)\DS@TOEJV&5YZCPF$+95^%^IT<GS@+4
M]5KOW?EI_53($'I?"6@$JG#C,ZP::4E>2NUCO=@SO2,IV7@8"H2O!#005;@)
M&E:-MM% =8R"B0S?^3\RA&*OPL)@IT84VH,9X?PVT\9E'1QVC@RAM*NP MBI
M$87V_8RJB1GO?E%RD4XW>VA#U#T%H/2KL,XWJ!DG"LN7K?SK787!$#BLP8^,
MJ )_KUJLIZ/$L5T7LC[MBX0H#_Z0/30 U=C ZE=\YA \I%.J]F==N3/6_= :
MCO)2T'#@)L)0]3@GXKVG*@3/PP=V4/!52'E="G$VH&4CSN(NER0XOS\P@X*N
M0G[KT(?"^9:()Y7-TWAE']1-J;VOHW?''R## E8 C4T5,M^3F.!<D7AY\F7^
M@%+]D*7Y]W 8_X+7)8+EH#&J0E(,(8 T=](ON^9H<KMZI&.J[&*+(5VFMZ:A
MI_!4"E <&JAJ/!,*S,,1KW>-@D#3Y-/V4^>'![4%OSF@\*4&.8&CK^9H_+^Q
MKVK,\<4AW[9!SQ=__ \V&OJB$-R6-\>K_66_]<>\\R=02P,$%     @ E4MN
M64TF@[ E(   )%8!  H   !E>#DY+3$N:'1M[3UK<]NVLM\UH_^ Z]-FG!E(
M$?56['J.8SNM6\=V8Z>=WB]W8!*RT%"DRH<=]=??70#4BWI1D61*9F=.CTN1
MP +8]RYVCW^Y_W1UDL\=_W)Q>@[_3_"?X_O+^ZN+D^-WZO_AUW?ZY^,/-^=_
MD;O[OZXN?CIHNT[PGABE7D#N19?[Y)H_D\]NESE4/:#DCGNB?0 ?PJ>W2;\[
M(EWF/0JG$+B]]P1>'SQX<(/ [8X_LWD;1BT=D8!_"PK,%H_.>^*)QTYP<'+\
M\>;Z?G3Z0IMUA=U_OP@ ^:XO_N4*WH.3-\Z#WSLZ?H<#P@;=[M'2CC^<7'SK
MB <1Y'.M5M$X?O?A9"\7.OT,[T\_7%V0LXNKJ[O;T[/+ZY]_.B@=R/^^/3T_
MC_X[\?*?A15T\-72CT?DP?4L[A5,U[99SP> HK\.).D=WW]./L$3]P)A,CO:
M+MCH TW(Q_?G*P-<*_VX5N2Z_/0SN?M\]M,!_]9J%8S_*Y6,XM^]QP-R>G7_
MT\$!\8.^S7\Z4+.7RZ7>MX,A]MV??\^*8L@TNLCX!G:%9=E\*LCE.2 W-<@
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MH>VZ>,E0LR1 %H_UA 7(AP0FD8UY7WDPH"A-& /^-J ."8W,S0/ER"0,,\&
MWPW"QZ3#$$Z\[J5H@Q'/?0@'-Z,E>*&,/,.O;8_!6*$9A)@'AAXS_#Q$+FK;
M!?Y/*'H]E:#8Y3S _#B$U8)M0-5*^H8CGL'E.AVY"\] +)$*!=H_TI7MNE]A
M''1/2$)LASCG@.1@H6W%-"04\(;/"6^WY?5]F8$WX)3MD-MR+E^IF_G<@+M%
M007\M2M\7Q,^=SKR<>02<R/O8Y1X!Z "(Y3A45@?';VJ-^"E XKVB_J0]A7M
M]YFF04.\1VT@G_M=9T1]C&Y)HB\:+TEFNN)N+D[7]4!>[<75OBCS33HD1N]?
MT>'- ZE6_E!NJ83:D2OD<CBP,5U/77<!;B]<"Q4[5!;^=CWTH\ $^!J^4, 4
M7OEJ/A==="!BR&_P/6;^@[EKD6(W[3KZE8IXNEX?%RTSGRFYNCHCA[>W5W=O
MBX-2)C T0 =;*U"B1!?5=&ZA8GH@--00I,WY6![F ^Z#5 ;GWR&2$4JJ@QI:
MK0*JT=OD3\X+0B[0M^I')E9"HZO"M=JJAWGQI]DZTLZ@X H)3>4LH2E+:,H2
MFC+AI>+@BC^.)L* H8%Y**A$@Y[\0[E1E=)IKI"+R;1*I33VE?J9/=A<RS(=
M_ZTHF69Q);/R.9260]%BA3*5%1TH,-GG-ZS;.SHG]E!,^<JBQC5(XT&N ./.
M_D2L8U+Z@3R+G Q2SI)1.;NG9[[7"'T&.H5*R9J#S*U5<-DHU1=^-8''J/3E
M<T,\9D'@"; :)0$,$1I,Z3:75B/H)JB2S$1)T'ILJ>J@=8D>..4SDZ2E%TZT
MD=Z?%2#/YSYB\!IIY=P+'R>OW1U^/#]]2WKB2>9NS%/,!C/"HECF:MK%Q=UQ
MJ8/3?$YIT;;*NQO!"+Q^."$)1FI()*.@<K$4^S(F$=!R&2&E@1DS+A$B2E*D
MP)SA>WB=2GJ<8#C?=1QNCUWAE/<^M1]*IG.PT#$["'(\76.8@H$UCAZYK'VD
M[! 4([BP.=NFQ8^\Q01B)J./'5S<-0<#UG9]?SZF1\9]:6C<P^L_E(I&'=&0
M^!V&/D>&CRK#U+<N7H=686.))HPX/"!R.E6L9? N$*@:L#PVX&*U:D_/9:^1
M[HSY6A\WX2^IT(*HEYF=3&)&O&0:U;RY5&S.]B\-?]/CG'-3#V-0S7+OP@=?
M^@@"';G*Y[AC13ZF&6Q^5D$[XC$ATRL>'X&AHJO^T4/DQNH G%L1EC=&DT'9
MG.P+O2GSTB]T0@>,-2B(8&15Y79V<<<?3DX?W!"8\**BB9GO?!<7-[.$MCI6
M]/=B<H4N&#*MI.7@XH@_6;IRI&IE5*HRXF,R60%_D$'U@M\#+N.%7?U)/B<K
M4R _\942.IEBK(I9Z>M#=(DZ/A1=Y6P,;IG).PA]^AWWV5'%0'Q0MC%O'_8$
MQ#[")F_?!,J]H0IXFD/K;IG2G<7Y!0A\'05&5HU@COC_SY41C?FH]PCPX=7Y
M_5O,7H$U+QDZ4.MGXU5PAQ5O$>Q9Q%TD'V&57==#M1[O%4D3%7;E"7TX",/S
M\W,1OF;Z:ZR+6@2YAW/NJU]_7V@?>#N<+@;F"U>N^U7*]SO,II&$EW'TW5P<
MWNA@PM&UZN51#G)/>C)1SN,RFP[U.%A< #9\E&/2UNA@*W0@PR&B]!349+5O
M3&=)12R]K7.K? [\454VL-FS7\SG_G0]4#7]$*Q\X&YZJB[K#W)>HD<8WIA\
MB"D@D\^ 5X>V-?GT@=N8_#?Y&)TGYF#8?$X_9DX /+T'ZXM] )O2G?(\2LF9
M?*[OIDP^C@J0QU]W_YX&$*C0SN2[>!'!L:*'P(E] 4C!9&$;3SDL?6GICIPU
M*OJJ9)/\&J2CW)BV?"_2V]6FJ,0E2N1%M]EG+T6P+^/A,]Z0F3P/,D,S[($X
M&DRCMU)E'S'?#[N]8;*4BD3SD7$P>R^"/FE.XM'T!+TY<O=H))=KJIMV;G*7
MD*&-T>0N/B.WZVCZI=X'O$_<GYYB1<8SK/(YG"V68K5PX"@M"K]>4UI4/A?/
MBSH:E(J+YM8\08.F0)&*Y-K42- 1%^J19$*-7(S#H!4A<2+ 3\S#JR^R-)PZ
M_Q#'1-X:2/T8SJDO>TP\=P2R-@_7@$FNH1V,WUEC@;[K:3*\XLW,()3Y$ZHT
M.[R*WP&X2"KHR<=<-W1'3:/6&"7AF[@98'9CB4Q<H;R<CMXMH'N5Z2S+T\^F
M[\LNNF,Q0;G-,"W#7PEHX"$SH=:T#KRFB_G'LHJ]3Q?B[S#'<(P#R#"CI%V)
MVD,Z/5(>D^^A-;(V4L,,X'6G(!ZM0&;YW&;-M1$RHP-.H/H41.@$ YJA+[LC
M:%8YN96GLN:@;MR$[B-03;N@TA1^&QA:,@RG>A;$'&<T2@"7AHUVH+6%+:\\
M#VX-W%V<C21 @8HT?%>Y;86IJZ#Y$0@^PO"['+U9^ W]<T#K2TE"C+&PJ( E
M%FX3FH#EZ?0!@078<RQ0G P$)5<ZTL1@79!I<@C-3P9CN#J5=NHL1?)G1]AC
MY22(5I!\G60[L8@QA1$GQFB.ZZ!/F^+?LB2<Q(>8(BGS>%F($\.Z,5\7V1^Z
M!(%G8NH O"A4?JZSB!>!F=L9,S:'B=-Z-CF]K&)JJ;Q@-L!32U]C'GU_B)+1
M/E@N[ %"&6(MT8!]Y1(H]P%4?J;O#.1S84^.-A=<%0W6Y3$!7%D;>(#KT]5N
M"@=O<C C&%K]>"KPBPYF(:ON =<V921AJ$GG<U*5WE.+9:_-,3"RL58.DFAF
M4>_FXN9U&EQ3M[V4]E;:8XS]-01AF,^=XD7[&\S1=)T]76ET]5[:*G@S-L2D
M(:DE[.F*C[^<_,W<_\YP2^_IHO>=!5\ZH+I*-/XLE2Z)OOO,?-?:SC6E:\35
MG3/T*OT,ZK37/_Z I3\^<^NL(WI:84=/L@PQR]^,0K-4*GR^."^<_7)Y2PX;
ME4JA7*TVWJJ?;SQ2+34*U991J%9;3?40^ $V\/LOJ-@FC+N0$>SVMJYP%Z6:
MW47)[J+LQEV4:4VYER"X+4K:-0O5E^NBOD1FSZZM%4QQ"U.IL:$X*!#(H60V
M_P=F2__478?S!8;Z3BUY#;6@D_"=Y>I.(5>8PY34]AQ$S&-ZN2O%J$:YSWBA
MKL*S[)R!H]G6$7!E60]TL/5&;_SKX5QG-[@)US\=E _FC#>-"RT4A+=3Y6H<
M+?!6P$A^J3JV)-6LEODG 32J*?IMK/S8E$W5*#BZ6?M[2J-!B#0<4F5=AZ0*
M\*U&I N.81K=+GW$TWCE8>BPT!+ Q-].&V_5X:>H-Q,#+[U)@'. 8RK,AVS4
M]6#XQX?#<JE*RY4F+==J;Y?9R(.3T[N[B_N[A80T@V96/Z E/YVZ9YN8=C\6
M^%T(]&<'4'XI&7FFP_',]T&U>3^?*A)*VJ4W9S46\#+0;)JP(XZL3']#:H%:
MDZI7?YR&-7@?A4R[CC*Y,#U,^<?Y%!+I;5,G^V'&H,8D;'J+&[4ZK35+L[Z:
M.L?T8WD)Z,NT639HK;$Z_!LAXVDX$@?CU#1A,!W[5PD7JE\=AH]!WW9XL&D"
M,VBEW*!&O9D6BF\:!JTWJFDG^0/ISW8P3W_3.U*NT4J]DI;S,9JTVMSF\7P/
MB<TP26X]WF/"&M[+'M*?.29MEU#&Y_.Z^=;*\JPUR3CZH*K5$BV5&TO9$\N"
ML4OKKX!<*!GK6/]VN4MYAK"X5ZU IN+GQE@/K55;U*BD1CI4:*M1IHUJ[049
M4(I5WW1!LVFZB<]^[3H%,[.7=D0ZHR#&U.]@HN[45A3?*B@R1BMF-KS4P55K
M35JO)-3R7L+2C4-TTXMN^:C\7KDB;"0NKQT@%6[G0%L56F_&Y/V+2:I&B5:,
M\LZ0HJJFRU_V#)L-L$6-A,)]D\:Q4:_19G4'K-&?7=?"JY:;WY(J %=MUM-S
M1BL!](*4=ND$S'D4>$- Z2A;(:U&LT4;Y83\:(.47JG0:F.;['%-\FZ&2^%&
M>@]VWVM@M&B]$:.E5^,T,.JT5(\IA=OV&6069THMSF4\-7$&42[6>@,'SG(L
M0G^2F$KD=\1R0Y N2X57$HZBSZ9.:[4R+1DQQ6CJ.E9G%2G?!L 3##[58F)L
MI6W(6,8^LHRET@JN+D\_7%Y=WE]>W)'3:_SVYNRW7VZNSB\^W^D;UN3B]R^7
M]W^E<0O3!4U&1CNWZROY>J.\&%NH:@J"9\[>5-N]@VR''NMC@L.*VQ.3W5.-
MW3)M53;M"UP&DCJ@-9C>Z2*FI<_+PP:=491\T^C<0J#CNM0+.O^J+=HTC)TA
ML"\.9QY6\-"=G3:]0^4J^M[2<EZ5"BW5$@:JTT%HDP&42*+UZ2#<CR5M!-YP
MWS#.PY$VC-0$Q5H 36F;1[K.$,K+G6*EV0"9DYI3K-1KM)HT@2T-E#G#U7OM
M8D%$K<3,/-Q=]'Z6ZPU::L8$WJOQ_K[I6LSO++.$%"05+Y<G-F(=;5P=H-46
M1DQ3HQ&4:;G:H,UR2K3O%%N%Z8)F2Q=K1I/%,B="&BAD3>H6]@!RV]O6NFI5
M,$!*J<D_:E90ZTH(S@LJSW.,H)<YSTJC1HU*0MFQ06'61/3:IC-BJUKT_#/>
M166RC/>88NB3Z=)9*D4FXY<T9F:P#F7A3+%L=I%.*K1:*=%6/$3P:CA%A5;J
M=5INO?A5K8Q7I)173 G^NMVN"'2M<U4X'75'[IA;<'2\\@/+R&1GR.0N<,VO
MV."&>WZ41X37K()^YN5(BS$LKZ.WN8?] WP\+PI:CT>P-[WL1PM&W[!C\1%H
M2F &RO^I)\#_PJ#C>N)?#N+5<:.GPO<Q>.]ZV+'$#W2;)!9,[7TK6]E/MN38
M^)E,MQ!>#$56 2<-!K:2AJXS WL:H]ACE.:BCP':*.!#O=J4*-&BE1;\EU&*
ML$G625@1G; )B6P\(YZXO?&B&2U88WHB$?4:;=1WYR[@J:6ZT("5A74R"L(A
M)NL)L+HV[D2M8,2?5I(6@-D<1%4D EEV8/<XPPS[^=0TPVYHR\*I%I>M<7?9
M?CRLE6B]T:!5(Y9CL*0%^7:GEU\%%HU7(%=V-K[-C((=U3(WRR>4G\V?:4/L
M,M54J('U@<JQN^:OQNU6I<U:#;$F<[MEK&,I?\*"FXTC#GG=;G=5QI'R:W_9
M[<=-WG[4#2@V6K1_O'G+BQ3QG]_0I98U=,D:NBS:F4TV=(E3Q)J[C:V/P/0#
M[/?-$$"_RVR[8,))K+\-5PI:@KRRCB]?HO8 LN.+:OY"QGJ_W W;'KMM<C/H
M);YT\\N4X_<, ;)K76"^VV0:='RHSVDHL5C\W7<\SLDG6&?')Q>R&SEVF2,3
M/5N20?F2"[H6SOK7LTH+D?5MR+R6(8LW1/6[V>8!?C>\RW@NTP3O_N_O&@A@
MI44M;ER3#;PU#X@6C97ZCU-Z+DU3U*]Y0#Z/W[Z>&&LSW3'*L[IC5&HE6HD7
M1TQ;=X]9\+>F=AO8$>@;U*A5:35^_VQ'X*\8+6I48ZSS93JKI-@/FT&S*]"D
MHMC7\*935%DE2\;+H$E_HN(T7#X7'C<#8KJ^3L3>5K$@@V)_&R-IP9?- =3
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M   +    9F]R;3@M:RYH=&WM/6M;XCJWW_D5.9RSW^T\(]"6BX(.[\-P4;R
M HZC7WQ"&R!:VM*+P/SZLY(6:*$H.GAAAOWLO=4V65DK65GWI(?_'?55]$A,
MB^K:MW_%N/ O(IJL*U3K?ONWT"Q6J__^-Q\Y[-G0#)IJUK=HS[:-7"(Q' [C
MPV1<-[L),9O-)D:L3=1ME!N%MI,$04S\/#]KRCW2QS&J63;69#+MI%+M83E\
M]G;:M&VJ--"4/9D,DDPL@(:WRJR#OW$FX;X,-+5#FZ;=IO:D*;7TE"3N/86'
MVV+:8;2LK<AP!@K)S^^-LUES.[S]K&G"-K%F=72SCVU80@8I'1.DF)3Q 8E9
M1 X @K_C7?WQ63C[L:0X@;.P.$%*V>LVMJ8SKI"YZ9Z,"2^@AY2:-'2L6!=C
M8]JX@ZTV!^N]F&]LZBJQ0EOS-X'FBFW&[+%!K'#$X76"O69]I)B0]%$KZXYF
MF^-P$KR7@:$LTUY$"AX&&GVO%BK35FVJXTZ':M0>VT3NQ66]SQN+HIB*LCU'
ML)*/(/;/H4UME>0/$^[/R&&?V!@Q.#$R<.CCMVA1UVRBV;$6D!-%LOO7MZA-
M1G:";\P$]$JX( __)Q9#%4I4)8>:Q#Y -=PG.3121@>H6N*_W E2Z>ZJ^8]4
M.BH4+N '0PS%8BMV3J;O&*EW(23>34A<'5I*F'9Z1>]T]HX SP$-\&^A3S0%
M_K,K*N[>=;!JD1= 2OH@E358BW$10)E8K6H*&9V2\9T $FY/E/8RTNI@,]]A
MIDMWXITG+%SX\.@%(*2[9@^;Q+J3[KAH=&%8_-D+P+ U+UUXH)(+""V#W=:5
M,;+LL4J^13O >CDD"H:-6K0/+6IDB!IZ'VN[[H-=&-^D'<;A"GV<=%.H9:AX
MG$.:KA'VCHYRC%N)"5N _T$5A6AL/["_H%7-Z0,<V>7UD=T@G6_1@E7O, Z)
MB6(,-A&BRK=H!<NVP/Y)1I$&1,-8A.8"C!#-<TXX3 0@_\Y8*?]8H:P2S<]X
M)6S@A)]FAH9).L0$W4PL_I[)VYS%%2F@@[AVS/5,AEF;XDYLLE'B(TN)>J^9
MK/L6M6C?4 D3"-XP <CN4);NF-Y(T(@O>\XCGA,Z1[PGIB8M"2=X\G#ZF"KL
M18<2$W'$2:A.*E9/@W,SWWDZ6")L-&\L R925Q90 *O M$O8)OD9]A,XLW?S
MO8!5EO29O)E#R3_ZY)DW?4NGM&+J_=D L]_N9,>R06X6]7Y?UYJV+C]<8/,'
M5AT2%X2]"V+R_7I.^FUB?LQ*S*:7=-F>FCWWWBB R<A0J4QM%T^D@"C0N-$9
M]?1\KFG#3++N115;P%^<U,*(6M$\4R:YE2;@,!$ZG@_31"BJ?QDSM4P0K;BM
MDFML@N%G6RW] G9\#PPXWS3_^3SUDGGXBUG+ 0N.\Q48 ?/LT"?8<DR2]XR%
M'#29@)J\"L!GL,*!NW;',O@>\;S-*P>8&3?S@X E BRX,*&L)U?*V-;-!0Y<
MG?9Y]$)@^D8L$4WO4^V9,9^=C_E!0\!.7OO)GY]&ST28602N:>+99H<)Z)N/
M1"*'QDLMP /4QV:7:C%;-W((FD\?M'4;A)3WC#%C#*NTJ^60#'N(":1#R\":
M?[Q8!_>I"N;C,R/RMA;]15P$ 5*"@8(?1GYC:?C/_XH9X2!(B<_<;S@JB5W@
M+O=T_#;W2J@/J6+WV$C"/]% [[9N @>XO;^K6'Y *9@M2U>I<H"\EQ-([GLQ
MGIZU\%/A)X*QD_=_'PV) !$;NU)_*K>]FA*.\>R_-\1]G\]_.W]5J[;*I4BS
M56B5FX>)]KK6Y/TI:9:+5XUJJUIN1@JU$BK_+!X7:D=E5*R?GU>;S6J]MI'D
M21YYU]CJ4:UKZ]INI!0OQI$DI%/9C23I3]@WE7KC/.)"9*84BQ=EA0P/B,5B
M)5UVF,G+HH]W\C18-PO;_2+&2:UR5%;MZR2 >V54)>N/JOC'C.;W8Z?S493I
M5&\YYOUQ!XX!Z=0HUUJ11OFBWFAM[C* 0V@YX!M&;!W:R"P]@L0DTDTDIG>4
M+TCO(+M'V"O'I#8%V.41>) :V"H%V6:OQ6PRM9FT;S(+;C+NS%F/ .<TB*&;
M-MIA?S-.(AA<,V+9B#S"F,CDKXGR)8=@P\U+Y^2<=+[@WG[9#06$B^E*I=?\
M\="YD@KT16+:31Q^B]*1G5-8R 7:]A0\'@/"1 N*<5$($^,!Y*+YFO[H!G7$
MU"YB(VVE^^? ?6(/S#-;VF,V-]G1(%UJL92RS?),X;S6J#1^WC]<W)+A_JM-
M E%<3+0$QV:!OGJA4JF"W7\3:96+Q[7Z6?T(K.9=5*T5XW\<7^V41S Y$38K
M3&*8T]E V$*606069E40A<6S+02*"@2(^>5M:'WK_6*ST"W,H:K"4YG5K$1!
MN+"_#:PHD[]?3(LOYC$-9<BZJF+# G0FO_$8XJ%MOAS^(S%M*F-UP@3@SGL!
MR4-;>36Z2>F?=[#JYO?]7F#?5S59-T$G\2(2'GPONK4215U9(@:.DS=E?7AY
M;.R_S#/PJ1Q6W\+"XC8Q3/V1<?Z"SI$6Y<23N((*)BH>@O9:14#8RN\OG_3/
M&^Z6=2#X,?Q5"?!7A:H$%@(,@W!FNI ZU1N\K_W0Q=?KE.0BK\S&9=DK,982
M4YGDEC,^E#.^!SBCA4=5+XDH\QW]%)N0WO7-^;YZ)-7(Z]DDI,9C"1+1?"H3
M2TNB**0S*S(-_,_\'/H%)FAC3!\NQ3FAX)WKX)6;Z!Z<<DNAW&WW&P]\-C:%
M,+W#\:5^C>4WV7YK&W].X;));,=*!:AE;3*',07',78EUI:Y/LO"[%3CC7@S
MSBDM]PU5'[-*E WELJ!R?(K?IOHOP7V\_%OYW_>.!0B-MX&=I696,F!F%13%
M));E_3BC&A'#3:RCBYNL;=\(]0?\>A,KO6ABA2 0S2>3@A"I85GO*KK< XH;
M.E:66%J[:)["PC,42N$49FO9HE4XJDM7OT%A9A4*I6B^Z5";($E<R7[<=);;
M#UN0(OQ:-UOZ4 M?#OGT1OM>REPX8^7UR[&W=#EFP\-B8"U2T&Q=H_K*3%8*
MHXG;JW7SPM0?P;9;$B Y+U1O]SN94>91?<, R?Y2RN>0C.9;9(2M)80OT!TJ
M/BYT0$:]I<;RL!!6N[7A>?76[G=>OYS9I40%,(CF]_8E<>]OV%HI;SD8.Q=,
M@I<OP*#3JY:+6O]:[WHXO789I$#"QS\RF#>2*'Q9,O$1;]0Y$HH>"6<ZN+@7
M/5U[,B)4J-C]1Z6A6/3U8D$*9!GFQXWF,]G]6#J97)ZC"OYX3W;RGE&-65X
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M=U7\VWS4^^:C.I'E&296[.^FJU P7447JKZ!R1!1B6P3!6DZSU0ZH(59*R#
MJRUG7S"BO,K;O=><\2 ?2QVS,-V0PM L0:$!^O#&)(_4@GX=JF%-9D5?6.9?
M]F&8LL]'*=A4++>JG,'WITEG]P#NX.D-@/[<57PA#2(&TR"CUA1=]^JS\!Q(
M^>+H?.]FD'FH/ZUA7I<03X9<=;*(V<J)\,WBS9"-]5OWF*^(_\?=SQVX?SLT
M@ILR/OQ^[M5F<8+-NW#<PHHQ.@\ U,!A914P(B>:FR:+"[ T1CZWFAEN1\SR
M<OX\W'R>+CC"8H)M+A&W:*[,_-^0PJ+@/*BDPWM,;:X QTT68J)C)PK6^R[
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M/3053FGALW_6++U6!+^/<R^(!;9_.R";6B_ZAS2?L!(<ZW-L4HQNL:81]AF
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M_>S9?37__U!+ 0(4 Q0    ( )5+;EF-4V%BTP,  .@.   1
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M  !E>#DY+3$N:'1M4$L! A0#%     @ E4MN66EWJEZT%   3*$   L
M         ( ![T,  &9O<FTX+6LN:'1M4$L%!@     &  8 >0$  ,Q8
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BIAF="http://bioaffinitytech.com/20241114"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="biaf-20241114.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <context id="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue.007PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <context id="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:TradeableWarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-14" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-14" id="Fact000004">0001712762</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-14" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-14" id="Fact000010">2024-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-14" id="Fact000011">BIOAFFINITY TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-14" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-14" id="Fact000013">001-41463</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-14" id="Fact000014">46-5211056</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-14" id="Fact000015">3300 Nacogdoches Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-11-14" id="Fact000016">Suite 216</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-14" id="Fact000017">San Antonio</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-14" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-14" id="Fact000019">78217</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-14" id="Fact000020">(210)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-14" id="Fact000021">698-5334</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-14" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-14" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-14" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-14" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-14" id="Fact000026">true</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000027">Common     Stock, par value $.007 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000028">BIAF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-11-142024-11-14_custom_CommonStockParValue.007PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000030">Tradeable     Warrants to purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000031">BIAFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-11-142024-11-14_custom_TradeableWarrantsToPurchaseCommonStockMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-11-14" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
